Pharming Group NV (PHAR)
11.77
+0.31
(+2.71%)
USD |
NASDAQ |
Aug 25, 16:00
11.96
+0.19
(+1.61%)
After-Hours: 19:59
Pharming Group Total Liabilities (Quarterly) : 210.95M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 210.95M |
| March 31, 2026 | 220.41M |
| December 31, 2025 | 233.34M |
| September 30, 2025 | 209.14M |
| June 30, 2025 | 218.93M |
| March 31, 2025 | 187.89M |
| December 31, 2024 | 190.30M |
| September 30, 2024 | 199.72M |
| June 30, 2024 | 206.08M |
| March 31, 2024 | 235.72M |
| December 31, 2023 | 252.18M |
| September 30, 2023 | 226.52M |
| June 30, 2023 | 229.43M |
| March 31, 2023 | 223.65M |
| December 31, 2022 | 227.40M |
| September 30, 2022 | 182.07M |
| June 30, 2022 | 194.23M |
| March 31, 2022 | 198.78M |
| December 31, 2021 | 210.21M |
| September 30, 2021 | 207.39M |
| June 30, 2021 | 213.77M |
| March 31, 2021 | 222.94M |
| December 31, 2020 | 236.02M |
| September 30, 2020 | 214.71M |
| June 30, 2020 | 212.89M |
| Date | Value |
|---|---|
| March 31, 2020 | 206.63M |
| December 31, 2019 | 141.29M |
| September 30, 2019 | 142.10M |
| June 30, 2019 | 146.11M |
| March 31, 2019 | 146.52M |
| December 31, 2018 | 174.69M |
| September 30, 2018 | 167.89M |
| June 30, 2018 | 164.28M |
| March 31, 2018 | 171.04M |
| December 31, 2017 | 176.98M |
| September 30, 2017 | 158.11M |
| June 30, 2017 | 137.10M |
| March 31, 2017 | 109.63M |
| December 31, 2016 | 104.75M |
| September 30, 2016 | 38.07M |
| June 30, 2016 | 39.45M |
| March 31, 2016 | 39.59M |
| December 31, 2015 | 36.76M |
| September 30, 2015 | 40.84M |
| June 30, 2015 | 24.81M |
| March 31, 2015 | 26.29M |
| December 31, 2014 | 31.31M |
| September 30, 2014 | 31.43M |
| June 30, 2014 | 39.44M |
| March 31, 2014 | 35.96M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ProQR Therapeutics NV | 61.83M |
| NewAmsterdam Pharma Co. NV | 73.03M |
| argenx SE | -- |
| DBV Technologies SA | 62.80M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 467.98M |
| Shareholders Equity (Quarterly) | 257.03M |
| Debt to Equity Ratio | 0.4931 |
| Current Ratio | 3.010 |
| Net Debt Paydown Yield | -0.15% |